Palo Alto – September 19, 2016 – Cooley performed the patent due diligence on behalf of LSP in connection with its Series C investment in Vivasure Medical.
LSP led the round with $18.3 million from its LSP Health Economics Fund. The funding will support European commercialization of Vivasure’s PerQseal technology to meet the growing demand for absorbable, percutaneous vessel closure products, as well as execution of an FDA regulatory study.
LSP is an independent European investment firm, providing financing for private and public life sciences companies. Vivasure is a medical device company based at Europe’s leading medtech cluster in Galway, Ireland.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.